患者视角:生活质量与疾病负担能否成为系统性红斑狼疮的治疗目标?
本文讨论系统性红斑狼疮(SLE)治疗目标从生存与防器官衰竭向临床缓解和低疾病活动度的演变,指出现有目标未充分覆盖健康相关生活质量(QoL)和疲劳。INTEGRATE项目分析患者与医生视角以设计创新治疗策略,并提出共享决策(SDM)可将QoL与疾病负担纳入治疗决策。
要点
- SLE治疗目标已从生存转向临床缓解和低疾病活动度
- 即使达到缓解,QoL和疲劳仍控制不足
- 共享决策可将患者视角的QoL与疾病负担纳入治疗策略
核心结论
- 当前SLE治疗目标未充分解决患者健康相关生活质量和疲劳问题,需以患者为导向的研究和共享决策将QoL与疾病负担纳入治疗决策。
研究设计与样本
- 本文为综述/观点性文章,讨论SLE治疗目标的演变并介绍INTEGRATE项目分析患者与医生视角。
主要发现
- 几十年前SLE治疗目标为生存和预防器官衰竭,现今临床缓解和低疾病活动度被视为最佳治疗目标。
- 许多患者难以达到上述目标,且即使处于缓解状态,QoL和疲劳仍控制不足。
关键数值与推荐
- 临床缓解和低疾病活动度被视为SLE最佳治疗目标。
- 即使达到缓解状态,QoL和疲劳仍控制不足。
临床怎么用
- 在SLE治疗决策中采用共享决策,将患者视角的生活质量和疾病负担纳入治疗策略。
- 开展以患者为导向的研究以设计新的狼疮管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A few decades ago, the therapy goal of patients with systemic lupus erythematosus (SLE) was survival and the prevention of organ failure. Today, clinical remission and low disease activity are believed to be the optimal therapeutic targets. These aims are difficult to reach for many patients, but they still do not address the health-related quality of life (QoL) that is significantly impaired in SLE patients. Even in the state of remission, QoL and fatigue are insufficient controlled. Thus, patient-oriented research is essential to design new strategies for the management of lupus patients. The INTEGRATE project analyses the patients' and physicians' perspectives to pave the way to design an innovative therapeutic strategy for lupus and focuses on the multifaceted dimensions of the disease burden. Shared decision making (SDM) could include the patient's perspective of SLE to treatment strategy and consider QoL and the burden of lupus into the process of therapy decision.
引用
- Kernder A, Elefante E, Chehab G, et al. The patient's perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus? Rheumatology (Oxford). 2020. PMID: 33280017. doi:10.1093/rheumatology/keaa427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。